BRPI0814343A2 - Materiais e métodos para a seleção da sexagem do esperma - Google Patents

Materiais e métodos para a seleção da sexagem do esperma

Info

Publication number
BRPI0814343A2
BRPI0814343A2 BRPI0814343A BRPI0814343A BRPI0814343A2 BR PI0814343 A2 BRPI0814343 A2 BR PI0814343A2 BR PI0814343 A BRPI0814343 A BR PI0814343A BR PI0814343 A BRPI0814343 A BR PI0814343A BR PI0814343 A2 BRPI0814343 A2 BR PI0814343A2
Authority
BR
Brazil
Prior art keywords
methods
materials
selection
chromosome
sperm
Prior art date
Application number
BRPI0814343A
Other languages
English (en)
Inventor
Hudson Keith
Ravelich Susan
Original Assignee
Androgenix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Androgenix Ltd filed Critical Androgenix Ltd
Publication of BRPI0814343A2 publication Critical patent/BRPI0814343A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0612—Germ cells sorting of gametes, e.g. according to sex or motility

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MATERIAIS E MÉTODOS PARA A SELEÇÃO DA SEXAGEM DO ESPERMA. Materiais e métodos para a separação de espermatozóides portadores de cromossomo X e Y, por exemplo, em uma amostra de sêmen, são fornecidos. Os métodos envolvem contatar a amostra de sêmen com um agente ligante, tal como um anticorpo, que se liga especificamente a um antígeno que é específico para um cromossomo X ou cromossomo Y. Kits para uso nos métodos também são fornecidos.
BRPI0814343A 2007-07-23 2008-07-23 Materiais e métodos para a seleção da sexagem do esperma BRPI0814343A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95136307P 2007-07-23 2007-07-23
US2983508P 2008-02-19 2008-02-19
PCT/NZ2008/000177 WO2009014456A1 (en) 2007-07-23 2008-07-23 Materials and methods for sperm sex selection

Publications (1)

Publication Number Publication Date
BRPI0814343A2 true BRPI0814343A2 (pt) 2017-10-03

Family

ID=40281571

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814343A BRPI0814343A2 (pt) 2007-07-23 2008-07-23 Materiais e métodos para a seleção da sexagem do esperma

Country Status (8)

Country Link
US (1) US20090208977A1 (pt)
EP (1) EP2181331A1 (pt)
CN (1) CN101821623A (pt)
AU (1) AU2008279893A1 (pt)
BR (1) BRPI0814343A2 (pt)
CA (1) CA2692006A1 (pt)
MX (1) MX2010000680A (pt)
WO (1) WO2009014456A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0401765C1 (pt) 2004-05-17 2011-03-15 Hy Biotecnologica Ltda método de enriquecimento de espermatozoides de mamìferos portadores de cromossomo x ou de cromossomo y
DK2761275T3 (en) * 2011-09-30 2017-09-25 Inguran Llc METHODS FOR COLORING AND SORTING SPERMA
US10379026B2 (en) 2012-08-29 2019-08-13 Inguran, Llc Cell processing using magnetic particles
RU2015111211A (ru) 2012-08-29 2016-10-20 Ингуран, Ллк Удаление или идентификация поврежденных или ослабленных клеток или клеточных структур при помощи магнитного воздействия
DK3492603T3 (da) 2012-10-05 2022-10-17 Inguran Llc Fremgangsmåder til behandling af sædceller til kønssortering
US10620213B2 (en) 2012-10-05 2020-04-14 Inguran, Llc High pressure sperm sorting and flow cytometer methods
KR101497614B1 (ko) * 2013-12-06 2015-03-03 손중호 마그네틱 비드를 이용한 정자 성 분리방법
AU2015219008B2 (en) * 2014-02-19 2020-10-01 University Of Tennessee Research Foundation Antibody for skewing sex ratio and methods of use thereof
WO2016156990A1 (en) * 2015-04-03 2016-10-06 Nanocell Ltd. Compositions for remodeling extracellular matrix and methods of use thereof
KR101916959B1 (ko) * 2015-07-13 2018-11-08 김동구 정자의 성 감별용 항체 및 이의 용도
JP7005498B2 (ja) 2016-01-04 2022-01-21 ユニヴァーシティ オブ テネシー リサーチ ファウンデーション 精液特性の改善方法
CN106544411A (zh) * 2016-08-27 2017-03-29 华中农业大学 一种利用标识蛋白分析鉴定哺乳动物y精子分型的方法
US11760793B2 (en) 2020-12-18 2023-09-19 University Of Tennessee Research Foundation Antibody for skewing sex ratio and methods of use thereof
US20230093352A1 (en) * 2021-09-21 2023-03-23 Cytolutions, Llc Sexed Sperm Bulk Separation Systems
CN114137231B (zh) * 2022-01-29 2022-04-29 北京大有天弘科技有限公司 一种血型不规则抗体的检测试剂盒及其应用
CN115785203B (zh) * 2022-06-10 2024-03-12 河北博海生物工程开发有限公司 肺癌特异性分子靶标10及其用途
EP4492061A1 (en) 2023-07-11 2025-01-15 Universidade de Trás-os-Montes e Alto Douro Sex-specific sperm membrane proteins for sperm sexing

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448767A (en) * 1977-10-11 1984-05-15 Sumar Corporation Preparation of monospecific male-specific antibody and the use thereof for increasing the percentage of mammalian offspring of either sex
US4999283A (en) * 1986-01-10 1991-03-12 University Of Kentucky Research Foundation Method for x and y spermatozoa separation
US5021244A (en) * 1988-12-06 1991-06-04 Cytogam, Inc. Sex-associated membrane antibodies and their use for increasing the probability that offspring will be of a desired sex
US5346990A (en) * 1987-04-08 1994-09-13 Cytogam, Inc. Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
CA2055494C (en) * 1989-05-10 2000-01-18 Lawrence Arthur Johnson Method to preselect the sex of offspring
AU722913B2 (en) * 1995-08-11 2000-08-17 University Of Guelph Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
ATE326228T1 (de) * 1997-07-01 2006-06-15 Vicam Lp Verfahren zur geschlechtsbestimmung von säuger- nachkommenschaft
US5985216A (en) * 1997-07-24 1999-11-16 The United States Of America, As Represented By The Secretary Of Agriculture Flow cytometry nozzle for high efficiency cell sorting
CN1414975A (zh) * 1999-12-07 2003-04-30 圭尔夫大学 性染色体特异性蛋白质,种特异性和精子特异性蛋白质以及它们的鉴定和分离方法
EP1255831A2 (en) * 2000-01-19 2002-11-13 The University Of Virginia Patent Foundation Sperm specific proteins
US20040142384A1 (en) * 2003-01-16 2004-07-22 Cohen Barb Ariel Magnetic separator

Also Published As

Publication number Publication date
MX2010000680A (es) 2010-06-01
CA2692006A1 (en) 2009-01-29
US20090208977A1 (en) 2009-08-20
EP2181331A1 (en) 2010-05-05
CN101821623A (zh) 2010-09-01
AU2008279893A1 (en) 2009-01-29
WO2009014456A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
BRPI0814343A2 (pt) Materiais e métodos para a seleção da sexagem do esperma
BRPI0510716A (pt) uso de um agente de ligação bi-especìfico, agente de ligação bi-especìfico, composição de um agente de ligação bi-especìfico, e, kit
HN2008001104A (es) Compuestos para anticuerpos de dickpf-1 y70-4
GT200900035A (es) Anticuerpo especifico prlr y sus usos
BR112012019693A2 (pt) anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
CO6680656A2 (es) Anticuerpos para metaloproteinasa -9 de matriz
BR112015011378A8 (pt) artigo compreendendo uma superfície impregnada com líquido e método de uso do referido artigo
CL2007000478A1 (es) Anticuerpo humano o humanizado o fragmento funcional del mismo especifico para linfopoyetina estromal timica, tslp; polinucleotido que lo codifica; celula huesped que lo comprende; composicion farmaceutica que comprende al anticuerpo; y metodo para t
CL2019001671A1 (es) Anticuerpos específicos para fcrn (divisional solicitud 201601147)
BR112012012917A2 (pt) anticorpo, ácido nucleico, vetor, célula hospedeira, método para a produção de um anticorpo ou um fragmento do mesmo, composição farmacêutica, método para tratar ou prevenir uma condição médica em um indivíduo, uso de um anticorpo ou fragmento do mesmo, e, métodos in vitro para neutralizar il-10 em uma amostra, in vitro para detectar a presença de il-10 em uma amostra e para diagnosticar lúpus eritematoso sistêmico (sle) em um indivíduo
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
BRPI0812878B8 (pt) anticorpo isolado ou parte funcional do mesmo, vetor, método para produzir um anticorpo ou uma parte funcional do mesmo, para produzir uma célula produtora de anticorpo e para produzir um anticorpo capaz de se ligar especificamente a rsv, composição, e, uso de um anticorpo ou parte funcional do mesmo ou de uma composição ou de vetor
CR20160206A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5
CL2007001536A1 (es) Anticuerpos anti-cd22; polinucleotidos que los codifica; vector y celula huesped que los comprende; metodo de fabricacion; metodo de deteccion del anticuerpo en una muestra biologica; inmunoconjugado que comprende al anticuerpo; composicion que lo comprende y su uso para tratar trastornos proliferativos de celulas b.
SV2008002972A (es) Composiciones, metodos y usos de anticuerpos humanos anti-il-23 ref. cen5117sv
BR112014008382A2 (pt) anticorpo especificamente ligando a epítope no domínio sema do c-met
GB201014805D0 (en) Microfluidics based assay device
CL2011000117A1 (es) Anticuerpo de dominio (dab) que se unen a cd28 y previene la union de dicha proteina a cd80 y/o cd86; uso del anticuerpo para tratar una enfermedad inmune; y composicion farmaceutica que lo comprende.
CL2008003309A1 (es) Compuestos derivados de citosina (=4-amino-pirimidin-2-ona) sustituida, moduladores de quinasas de punto de control del ciclo celular; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento o la disminucion de la progresion del cancer.
MX2013013832A (es) Proteínas de unión receptoras fc.
BR112016002685A2 (pt) ensaios para timp2 que apresentam melhor desempenho em amostras biológicas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]